ResMed Inc.
RSMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $38 | $27 | $32 | $31 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $2 | $1 |
| Enterprise Value | $37 | $28 | $33 | $31 |
| Revenue | $5 | $5 | $4 | $4 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Gross Profit | $3 | $3 | $2 | $2 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| EBITDA | $2 | $2 | $1 | $1 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| % Growth | 37.4% | 13.6% | 14.9% | – |
| Operating Cash Flow | $2 | $1 | $1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $2 | $1 | $1 | $0 |